Wijngaarden MA, van der Zon GC, van Dijk KW, Pijl H, Guigas B. Effects of prolonged fasting on AMPK signaling, gene expression, and mitochondrial respiratory chain content in skeletal muscle from lean and obese individuals. Am J Physiol Endocrinol Metab 304: E1012-E1021, 2013. First published March 19, 2013; doi:10.1152/ajpendo.00008.2013.-Obesity in humans is often associated with metabolic inflexibility, but the underlying molecular mechanisms remain incompletely understood. The aim of the present study was to investigate how adaptation to prolonged fasting affects energy/nutrient-sensing pathways and metabolic gene expression in skeletal muscle from lean and obese individuals. Twelve lean and 14 nondiabetic obese subjects were fasted for 48 h. Whole body glucose/ lipid oxidation rates were determined by indirect calorimetry, and blood and skeletal muscle biopsies were collected and analyzed. In response to fasting, body weight loss was similar in both groups, but the decrease in plasma insulin and leptin and the concomitant increase in growth hormone were significantly attenuated in obese subjects. The fasting-induced shift from glucose toward lipid oxidation was also severely blunted. At the molecular level, the expression of insulin receptor-␤ (IR␤) was lower in skeletal muscle from obese subjects at baseline, whereas the fasting-induced reductions in insulin signaling were similar in both groups. The protein expression of mitochondrial respiratory chain components, although not modified by fasting, was significantly reduced in obese subjects. Some minor differences in metabolic gene expression were observed at baseline and in response to fasting. Surprisingly, fasting reduced AMPK activity in lean but not in obese subjects, whereas the expression of AMPK subunits was not affected. We conclude that whole body metabolic inflexibility in response to prolonged fasting in obese humans is associated with lower skeletal muscle IR␤ and mitochondrial respiratory chain content as well as a blunted decline of AMPK activity.
OBESITY IS AN ENDEMIC METABOLIC DISORDER affecting almost half a billion people worldwide. Human beings, like all living organisms, have to constantly adjust their metabolism in response to changes in environmental nutrient availability. Metabolic inflexibility, which reflects the inability to adapt tissuespecific substrate oxidation to whole body fuel availability, was suggested to be implicated in the development of obesity, insulin resistance, and type 2 diabetes (8, 11, 21, 36) . Thus, the shift from carbohydrate toward lipid oxidation during the transition from postprandial to fasting state is impaired in obese subjects (36) . Taken together, metabolic inflexibility is manifested in a range of metabolic pathways and tissues, notably in skeletal muscle (20) , but little is known about the underlying molecular mechanism(s) (5, 31) .
To ensure efficient metabolic adaptations to nutritional or environmental changes, various energy/nutrient-sensing pathways are mobilized in peripheral tissues (18) . Among them, the AMP-activated protein kinase (AMPK), a serine/threonine protein kinase, which acts as a cellular energy and nutrient sensor, is believed to play a crucial role in the regulation of tissuespecific substrate metabolism (7, 13, 33) . AMPK consists of a heterotrimeric complex containing a catalytic ␣-subunit and two regulatory ␤-and ␥-subunits. Each subunit has several isoforms encoded by distinct genes, giving multiple heterotrimer combinations with different tissue distributions and cellular localizations (7, 13, 33) . The ␣-subunit contains a threonine residue (Thr 172 ), whose phosphorylation by upstream AMPK kinases, such as the liver kinase B (LKB1) or calmodulin-dependent protein kinase kinase-␤ (CAMKK␤), is required for AMPK activation. The ␤-subunit acts as a scaffold to which the two other subunits are bound, and contains a carbohydrate binding site that allows AMPK to sense energy reserves in the form of glycogen (7, 13, 33) . Binding of AMP and/or ADP to the ␥-subunit activates AMPK via a complex mechanism involving direct allosteric activation, phosphorylation on Thr 172 by AMPKK, and inhibition of dephosphorylation by protein phosphatase(s) that remain to be identified (7, 13, 33) . Thus, any change in cellular energy status activates AMPK, leading to concomitant inhibition of energy-consuming processes and stimulation of ATP-generating pathways to restore energy balance (7, 13, 33) . As a result, glycogen and protein synthesis, as well as cell growth and differentiation, are inhibited, whereas fatty acid (FA) oxidation and glucose uptake are stimulated (7, 13, 33) . This regulation involves phosphorylation by AMPK of key metabolic enzymes and transcription factors involved in gene expression (7, 33) .
The purpose of the present study was to investigate whether metabolic adaptations to prolonged fasting differ between lean and obese individuals and whether this is associated with changes in the skeletal muscle AMPK signaling pathway, as previously reported in rodents (6, 10) .
MATERIALS AND METHODS
Ethical approval. The present study (Clinical Trial Registration No. NTR2401) was approved by the Medical Ethics Committee of the Leiden University Medical Centre and performed in accordance with the principles of the revised Declaration of Helsinki. All volunteers gave written informed consent before participation.
Subjects. Twenty-six volunteer subjects, 12 lean (2 males, 10 females, BMI 23.3 Ϯ 0.5 kg/m 2 ) and 14 obese (2 males, 12 females, BMI 35.2 Ϯ 1.2 kg/m 2 ) were included. All of them were healthy, weight-stable, nonsmoking Caucasians with a fasting plasma glucose Յ5.6 mmol/l and without family history of diabetes. Height, weight, BMI, and hip and waist circumferences were recorded according to World Health Organization recommendations.
Study design. All participants were admitted to our research center after an overnight fast. The intervention study started after a standardized breakfast (t ϭ 0, two slices of brown bread with cheese), followed by 48 h of fasting. Water and caffeine-free tea were allowed ad libitum. To ensure complete adherence to the study, the subjects were kept under supervision in our research center during the whole experimental period. Blood samples were taken after breakfast (t ϭ 90 min) and after 24 and 48 h of fasting by venapuncture in the elbow. Muscle biopsies (ϳ50 -75 mg) from musculus vastus lateralis were collected after breakfast (t ϭ 135 min) and after 48 h of fasting, as previously described (30) .
Indirect calorimetry. Subjects were placed under a ventilated hood after 45 min, 24 h, and 48 h of fasting (OxyconPro, Mijnhardt Jaegher). Substrate oxidation was calculated from CO2 and O2 concentrations in the exhaled air, as previously described (24) .
Laboratory analysis. Serum glucose, total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides (TG), and C-reactive protein (CRP) were measured on a Modular Analytics P-800 system (Roche Diagnostics). Low-density lipoprotein (LDL)-cholesterol was calculated according to the Friedewald equation (9) . Serum insulin and insulin-like growth factor I (IGF-I) were measured by immunoluminometric assay on an Immulite 2500 automated system (Siemens Healthcare Diagnostics). Cortisol, free thyroxine (T4; FT4), and thyroid-stimulating hormone (TSH) were measured by electrochemoluminescence immunoassay on a Modular Analytics E-170 system (Roche Diagnostics). Triiodothyronine (T3) was measured by fluorescence polarization immunoassay on an AxSym system (Abbott). Growth hormone (GH) was measured by immunofluorometric assay (Wallac, Finland). Serum active ghrelin, leptin, and adiponectin were determined by radioimmunoassay (Millipore).
Western blot. Skeletal muscle biopsies (ϳ30 -45 mg) were homogenized by Ultra-Turrax (22,000 rpm; 2 ϫ 5 s) in a 6:1 (vol/wt) ratio of ice-cold buffer containing 50 mM HEPES (pH 7.6), 50 mM NaF, 50 mM KCl, 5 mM NaPPi, 1 mM EDTA, 1 mM EGTA, 5 mM ␤-GP, 1 mM Na3VO4, 1 mM DTT, 1% NP40, and protease inhibitor cocktail (Complete, Roche). Western blots were performed using phosphospecific (Ser 473 -PKB, phospho-Akt substrate, and Thr 172 -AMPK␣ from Cell Signaling, Thr 246 -PRAS40 from Biosource, Tyr 612 -IRS1 from Invitrogen), or total primary antibodies (tubulin and AMPK␤1ϩ2 from Cell Signaling, AMPK␣1 and AMPK␣2 from Kinasource, AMPK␥1, PGC-1␣, and MitoProfile OXPHOS from AbCam, AMPK␥3, IR␤, and LKB1 from Santa Cruz Biotechnology, CAMKK␣/␤ from BD Biosciences; AMPK␥2 truncated was a kind gift of Pr. D. G. Hardie), as previously described (35) .
AMPK activity. AMPK heterotrimeric complexes were immunoprecipitated from 500 g of muscle lysate using protein A-agarose beads (GE Healthcare) and a pan ␣-specific AMPK antibody (Santa Cruz Biotechnology) incubated together at 4°C overnight on a rotating wheel. After incubation, the immunoprecipitate was washed twice in ice-cold lysis buffer without NP40 and once in ice-cold assay buffer containing 50 mM HEPES (pH 7.2), 80 mM KCl, 1 mM EDTA, 5 mM MgCl2, 1 mM DTT, 1% glycerol, and 1 mg/ml FFA-free BSA. The reaction was initiated at 30°C by addition of a mixture of 200 M AMP, 200 M SAMS peptide (kind gift from Dr. L. Bertrand, Brussels, Belgium), 100 M Mg-ATP, and 2 Ci of [␥-32 P]ATP (PerkinElmer). After 15 min, the beads were briefly spun down, and 20 l of supernatant was spotted onto P81 filter paper (Whatman, GE Healthcare). After extensive washing in 1% phosphoric acid, the filter paper was dried and analyzed for radioactivity using a Tri-Carb Liquid Scintillation Counter (Packard). The nonspecific activity (without SAMS peptide) was subtracted from the specific kinase activity, which was expressed in milliunits per milligram of protein.
RNA isolation and real-time RT-PCR. Total RNA was isolated from skeletal muscle biopsies (ϳ25-30 mg) using the phenol-chloroform extraction method (Tripure RNA Isolation reagent, Roche) and quantified by NanoDrop. First-strand cDNA was synthesized from 1 g of total RNA, using a Superscript first-strand synthesis kit (Invitrogen). Real-time PCR assays were performed using specific primer sets (sequences provided on request) and SYBR Green on a StepOne Plus Real-time PCR system (Applied Biosystems). mRNA expression was normalized to ribosomal protein S18 (Rps18) and expressed as arbitrary units.
Statistical analysis. All data are presented as means Ϯ SE. For metabolic parameters and indirect calorimetry, a mixed model was used to determine the effects of fasting in between groups. For Western blot and RT-qPCR, the data were analyzed with unpaired or paired t-tests for determining the baseline differences and within group effects, respectively. All the statistical analysis were performed using SPSS for Windows version 18.0.
RESULTS
Effects of fasting on body weight, body composition, and metabolic parameters in lean and obese subjects. The anthropometric and metabolic characteristics of the subjects were determined at baseline (postmeal), i.e., ϳ45 min after a standardized breakfast (300 kcal), and after 24 or 48 h of fasting (Table 1) . At baseline, body weight, BMI, and waist-to-hip ratio were significantly higher in obese than in lean subjects. Plasma glucose, insulin, leptin, and triglyceride levels were also elevated in the obese group (ϩ11, ϩ148, ϩ204, and ϩ40%, respectively, P Ͻ 0.05), reflecting whole body insulin/ leptin resistance and glucose intolerance. In response to fasting, body weight was decreased to the same extent in obese and lean subjects (Ϫ2.8% vs. Ϫ3.5%, respectively). As expected, fasting induced a significant decrease in plasma glucose, insulin, leptin, T 3 and TSH levels, whereas circulating total cholesterol, LDL, growth hormone, CRP, and cortisol increased in both groups (Table 1) . However, the fasting-induced changes in plasma insulin (at 24 and 4 8h: Ϫ76 and Ϫ84% vs. Ϫ87 and Ϫ85% in obese and lean, respectively, P Ͻ 0.01), growth hormone (at 48 h: ϩ343 vs. ϩ900% for obese and lean, respectively, P Ͻ 0.01), and leptin (at 24 and 48 h: Ϫ22 and Ϫ43% vs. Ϫ45 and Ϫ66% in obese and lean, respectively, P Ͻ 0.01) levels were significantly attenuated in obese subjects ( Table 1) .
Effects of fasting on whole body glucose and lipid oxidation rates in lean and obese subjects. The substrate oxidation rates were determined by indirect calorimetry at baseline and after 24 and 48 h of fasting (Table 2) . At baseline, the absolute resting energy expenditure (REE, in kcal/day) was significantly higher in obese than in lean subjects (ϩ24%, P Ͻ 0.05), an effect that, however, disappeared when the data were corrected for lean body mass (kcal·day Ϫ1 ·kg FFM Ϫ1 ). This metabolic feature is associated with higher lipid (ϩ62%, P Ͻ 0.05) and lower glucose (Ϫ22%, P Ͻ 0.05) oxidation rates. Fasting led to significant decrease in respiratory quotient (RQ), indicating a shift in substrate metabolism from glucose toward lipid oxidation in both groups (Table 2) . However, these fasting-induced changes were significantly attenuated in the obese subjects, with a lower reduction in glucose oxidation (at 24 and 48 h: Ϫ38 and Ϫ60% vs. Ϫ53 and Ϫ70% in obese and lean, respectively, P Ͻ 0.01) and a lesser increase in lipid oxidation (at 24 and 48 h: ϩ41 and ϩ76% vs. ϩ133 and ϩ214% in obese and lean, respectively, P Ͻ 0.01). In addition, the REE was also differently affected in response to fasting between groups, with a significant decrease evidenced only in the obese group (at 48 h: Ϫ7 vs. ϩ3% in obese and lean, respectively, P Ͻ 0.01; Table 2 ).
Effect of fasting on insulin signaling pathways in human skeletal muscle from lean and obese subjects. The protein expression and phosphorylation state of key molecules involved in the insulin signaling pathway were determined in skeletal muscle biopsies at baseline and after 48h of fasting ( Fig. 1 ). Tubulin expression, used as a housekeeping protein, was similar between lean and obese subjects at baseline and was not affected by fasting (Fig. 1A) . By contrast, insulin receptor-␤ (IR␤) expression was significantly lower in obese than in lean subjects at baseline (Fig. 1B, Ϫ18% , P ϭ 0.02), but its increase in response to fasting was similar in both groups (ϩ17 and ϩ18% in lean and obese, respectively). Downstream of IR␤, the phosphorylation of insulin-receptor substrate (IRS)1, protein kinase B (PKB, also called Akt), and PKB downstream targets proline-rich Akt substrate of 40 kDa (PRAS40) and Akt substrate of 160 kDa (AS160) on key regulating residues were similar between lean and obese subjects at baseline (Fig. 1, C-F ). In line with the decrease in plasma insulin levels, the phosphorylation states of these proteins were similarly reduced after a 48-h fast in both groups. Of note, protein expressions of IRS1, PKB, PRAS40, and AS160 were not affected whatever the conditions (data not shown).
Effect of fasting on AMPK expression and signaling in human skeletal muscle from lean and obese subjects. We next assessed whether prolonged fasting would affect the protein expression and phosphorylation state of AMPK␣ on its activating Thr 172 residue. AMPK␣ expression was similar in lean and obese subjects whatever the condition ( Fig. 2A) . Surprisingly, AMPK-Thr 172 phosphorylation, which was not different between groups at baseline, was reduced by fasting in lean (Ϫ19%, P ϭ 0.08) but not in obese (Ϫ1%, P ϭ 0.90) individuals (Fig. 2 , B and C). This borderline significant trend was confirmed by determination of AMPK activity using a kinase assay (Fig. 2D) . Furthermore, the fasting-induced change in the phosphorylation state of acetyl-CoA carboxylase (ACC) at Ser 221 , a main AMPK downstream target, followed the same pattern although not reaching a significant threshold (Ϫ18% in lean vs. ϩ4% in obese, P ϭ 0.07 and P ϭ 0.72, respectively). Although some differences were observed at the mRNA levels (Table 3) , the protein expression of the different isoforms of AMPK catalytic ␣-and regulatory ␤-and ␥-subunits were similar at baseline, except for the AMPK␥2 short isoform, which was significantly lower in obese than in lean subjects (Fig. 3) . The expression of all these AMPK subunits was not affected by fasting in either group, suggesting that the difference in AMPK response between lean and obese is unlikely due to changes in heterotrimer composition. Of note, the protein expression of the AMPK upstream kinase LKB1, but not of CAMKK␣/␤, was significantly increased by fasting only in lean subjects (Fig. 2, E and F) . Effect of fasting on metabolic gene expression in human skeletal muscle from lean and obese subjects. The mRNA expressions of key genes involved in glucose and lipid metabolism were determined in skeletal muscle from lean and obese subjects. At baseline, transcript levels of HK1, PKM2, PPARA, CD36, ACACA, ATP2A1, ACADM, ACOX3, and PDK4 were significantly higher in obese than in lean individuals, whereas LPL mRNA expression was found to be significantly lower (Table 4) . Prolonged fasting induces significant upregulation of INSR, PDK4, PFKFB3, and UCP3 and downregulation of HK2 and PPARGC1A mRNA expression in lean subjects (Table 4 ), in line with previous studies (25, 28, 37, 39) . Furthermore, we also report that SLC2A4, PKM2, CD36, ACSL1, NDUFB8, and ACAT2 were significantly reduced in response to fasting. However, among these key metabolic transcription factors and genes, only ACAT2, SLC2A1, and NRF1, were shown to be differentially affected by fasting in lean and obese individuals ( Table 4) . biogenesis, and of several mitochondrial respiratory chain complex subunits were measured in skeletal muscle from lean and obese subjects (Fig. 4) . At baseline, we found that, although PGC-1␣ expression was similar in both groups, all the respiratory chain subunits were significantly lower in the obese than in the lean subjects (Ϫ30, Ϫ30, Ϫ40, Ϫ43, and Ϫ21% for complex (C)I to CV, respectively, P Ͻ 0.05). The expressions of PGC-1␣ and mitochondrial proteins were not significantly affected by fasting in both groups, although a trend for a specific increase in the respiratory chain complex 1 subunit (ϩ25%, P ϭ 0.06) was observed in skeletal muscle from lean subjects (Fig. 4) .
Effect of fasting on PGC-1␣ and mitochondrial respiratory chain components expression in human skeletal muscle from lean and obese subjects. Finally, the protein expressions of PGC-1␣, a key transcription factor involved in mitochondrial

DISCUSSION
In contrast to the vast literature available on the signal transduction pathways involved in metabolic adaptations to exercise in human skeletal muscle, only a few systematic studies have been conducted to investigate the molecular processes triggered by fasting, especially in individuals with metabolic disorders. To our knowledge, this study is the first to report the effects of prolonged fasting on whole body substrate oxidation rates in relation to changes in signal transduction pathways and metabolic gene expression in skeletal muscle from both lean and obese subjects.
The physiological adaptation to fasting is generally marked by increased lipolysis, ketone body synthesis, and lipid oxidation and a concomitant decrease in glucose uptake and oxidation by peripheral tissues (31) . In lean individuals, we observed several of these well-known effects on whole body substrate metabolism together with decreased plasma levels of glucose, insulin, and leptin and a concomitant increase in GH. Not surprisingly, our obese subjects exhibited elevated levels of glucose, insulin, TG, and leptin and lower circulating adiponectin at baseline than lean individuals and a marked whole body metabolic inflexibility characterized by impaired fastinginduced switch from glucose toward FA oxidation. In addition, the decrease in plasma leptin and insulin levels in response to fasting was also blunted, in line with previous reports (15, 16, 23) . Among the limitations to the interpretation of these data, it should be mentioned that it cannot be totally excluded that some of the baseline differences between lean and obese individuals might partly reflect impaired metabolic adaptation to the initial standardized breakfast taken by the subjects. However, Labayen et al. (26) have also reported a lower RQ and higher lipid oxidation rate at baseline in obese women after an overnight fast compared with lean individuals, suggesting that these fundamental differences are independent of meal response. Interestingly, we found that the protein expression of IR␤ was reduced at baseline in skeletal muscle from obese compared with lean individuals. However, the IR␤ protein expression was similarly increased in response to fasting in both lean and obese individuals, likely reflecting a compensatory feedback mechanism triggered by reduced plasma insulin levels. In contrast to our findings, Bergman et al. (3) have found no effect of 48-h fasting on the expression of the insulin receptor. This discrepancy might be explained by the fact that their baseline samples were collected after an overnight fast, a nutritional condition that might be sufficient to already induce IR expression. Of note, IR␤ downstream signaling, reflected by the phosphorylation states of IRS1, PKB, PRAS40, and AS160, was similarly reduced by fasting in both groups. The fasting-induced increase in plasma GH levels is believed to play an important role in the regulation of whole body substrate metabolism, notably by inhibiting glucose uptake and enhancing lipid oxidation in skeletal muscle (19) . Interestingly, we found that the change in plasma GH levels was significantly different between groups, with a much larger increase in lean than in obese individuals. This result is in line with our previous findings showing that obese women exhibit lower plasma GH concentrations in response to a 20-h fast than normal-weight women (4), suggesting that GH hyporesponsiveness may contribute to metabolic inflexibility. At present, it is unclear to what extent the fasting-induced increase in GH modulates signaling pathways involved in the regulation of glucose/lipid metabolism in human skeletal muscle. However, it has recently been shown that fasting induced similar upregulation of lipid oxidation genes in skeletal muscle from wildtype and GH receptor (GHR) knockout obese mice, suggesting that GHR signaling is likely not required for the control of lipid oxidation during fasting (41) . Among the fasting-induced changes in skeletal muscle metabolic gene expression observed in our study, some were previously reported, such as upregulations of PDK4 and UCP3, and are likely contributing to the whole body shift from glucose to lipid oxidation in humans (25, 27, 28, 32, 37, 39, 40) . However, no major differences in transcriptional regulation in response to fasting were found between lean and obese individuals.
One of our initial hypotheses was that the nutrient/energy sensing AMPK pathway is activated by fasting in skeletal muscle and subsequently triggers metabolic adaptations to food deprivation. Indeed, although most of its established functions came from in vitro and/or rodent studies, it is largely acknowledged that AMPK activation promotes both glucose uptake and lipid oxidation in skeletal muscle through direct phosphorylation of key regulatory enzymes or transcription factors (12, 42) . In the present study, we did not find any differences in basal (postmeal) AMPK activity in skeletal muscle from lean and obese subjects. This is in line with most of the previous reports (14, 28, 34, 43) , although one study has reported reduced AMPK activity in skeletal muscle from healthy obese and type 2 diabetes individuals (1) . Surprisingly, we showed that fasting decreases skeletal muscle AMPK activity in lean subjects, an effect lost in obese individuals. Of note, it was also recently reported that 72 h of fasting does not significantly affect AMPK activity in healthy individuals (40) . One could therefore argue that fasting-induced AMPK activation is an early regulatory event that transiently occurs in the first hour following food deprivation. Additional experiments with earlier time points are therefore required to clarify this issue.
Why does AMPK activity decrease in healthy individuals in response to fasting and why is this effect lost in obesity? The regulation of AMPK activity is complex and involves 1) adenine nucleotides binding to the ␥-subunit, 2) Thr 172 phosphorylation by LKB1 and/or CAMKK␤, 3) Thr 172 dephosphorylation by AMPK-specific protein phosphatase(s), 4) phosphorylation of various regulatory residues on both ␣-and ␤-subunits, and 5) glycogen binding to the ␤-subunit (7, 13, 33) . In addition, modification in the AMPK subunits' composition might also influence the kinase activity by changing the sensitivity toward AMP and/or other posttranslational regulatory mechanisms. In human skeletal muscle, the majority of AMPK heterotrimers consists of either ␣2␤2␥1 or ␣2␤2␥3 complexes (43) . However, except for the protein expression of the marginal short AMPK␥2 isoform, which was significantly lower at baseline in the obese than in the lean individuals, all the other catalytic ␣-and regulatory ␤/␥-subunits were similar between groups whatever the conditions. Among the AMPK regulatory mechanisms described above, an increase in cellular energy status during fasting is rather unlikely, and no differences in the phosphorylation state of AMPK␣ at the inhibitory Ser 485/491 residue were observed (data not shown). A fasting-induced increase in protein phosphatase(s) activity cannot be excluded, but the identity of the enzyme(s) involved in AMPK-Thr 172 dephosphorylation remains uncertain (7, 13, 33) . Counterintuitively, we found an increase in LKB1 protein expression after fasting in lean but not in obese individuals that, however, merely suggests a compensatory mechanism secondary to reduced AMPK activity in the former group. On top of the cellular energy state, AMPK constantly monitors intracellular glycogen stores. Interestingly, a paradoxical increase in skeletal muscle glycogen content was reported during prolonged fasting (40) . It is therefore tempting to speculate that this physiological adaptation might be involved in reduced AMPK activity in lean subjects and altered in obese individuals with impaired glycogen metabolism. The determination of skeletal muscle glycogen content in our study would have clearly contributed to strengthening this point, but the amount of available materials was unfortunately not sufficient to perform this measurement. Finally, an attractive potential explanation emerges from a recent study showing that epinephrine inhibits AMPK by a mechanism involving activation of an unidentified kinase that phosphorylates the AMPK ␤-subunit on a new inhibitory residue (38) . Indeed, fasting is known to increase plasma catecholamine levels (2), an effect that was reported to be partly blunted in obese individuals (16) . Taken together, the physiological rationale for a reduced AMPK activity during prolonged fasting still remains unclear. One of the hypotheses builds on modulation of the so-called Randle cycle (17) : a reduced AMPK activity would therefore prevent glucose uptake by reducing AMPK-mediated GLUT4 translocation to the plasma membrane, leading to subsequent inhibition of glucose oxidation and the concomitant shift toward mitochondrial FA.
Finally, another striking finding is the marked decrease in protein expression of key mitochondrial respiratory chain subunits in obese subjects, strongly suggesting that the skeletal muscle mitochondrial content is reduced in these individuals. This may affect the capacity of skeletal muscle to adapt to increased FA availability associated with fasting and underlie the impaired shift from glucose toward mitochondrial FA oxidation. Although the underlying molecular mechanism(s) remains to be elucidated, this strengthens previous reports showing that mitochondrial density in skeletal muscle, assessed either by mtDNA content and/or by ex vivo determination of mitochondrial respiratory chain complexes activities, was reduced in skeletal muscle from obese subjects (22, 29) . In the present study, due to lack of materials we were unfortunately not able to measure other mitochondrial markers, such as mtDNA content or activities of citrate synthase and ␤-hydroxyacetyl coenzyme A dehydrogenase. Additional studies are therefore required to determine additional mitochondrial parameters and clarify the (patho)physiological consequence of these findings.
In conclusion, our main findings show that obese individuals are characterized by whole body metabolic inflexibility in response to prolonged fasting, a feature associated with apparent alteration in AMPK signaling and reduced skeletal muscle IR␤ and mitochondrial content.
